More about

Nonalcoholic Fatty Liver Disease

News
December 26, 2020
1 min read
Save

Best of NLA: Icosapent ethyl in COVID-19, dyslipidemia in pregnant women and more

Best of NLA: Icosapent ethyl in COVID-19, dyslipidemia in pregnant women and more

The virtual National Lipid Association Scientific Session took place from Dec. 10 to 12, and Healio and Cardiology Today have compiled a list of the most-read news from the meeting.

News
December 15, 2020
4 min read
Save

Diabetes, liver disease epidemics call for early detection, monitoring, lifestyle changes

Diabetes, liver disease epidemics call for early detection, monitoring, lifestyle changes

The inextricable, well-documented link between the twin epidemics of nonalcoholic fatty liver disease, or NAFLD, and type 2 diabetes has raised alarms in the medical community.

News
December 15, 2020
4 min read
Save

Diabetes, liver disease epidemics call for early detection, monitoring, lifestyle changes

Diabetes, liver disease epidemics call for early detection, monitoring, lifestyle changes

The inextricable, well-documented link between the twin epidemics of nonalcoholic fatty liver disease, or NAFLD, and type 2 diabetes has raised alarms in the medical community.

News
December 08, 2020
2 min read
Save

NASH drug helps reduce liver fat with good tolerability

NASH drug helps reduce liver fat with good tolerability

Patients with non-alcoholic steatohepatitis treated with BIO89-100 experienced clinically meaningful reduction in liver fat, according to research presented at The Liver Meeting Digital Experience.

News
November 16, 2020
2 min read
Save

Combination therapies impact NAFLD more than singular therapy

Combination therapies impact NAFLD more than singular therapy

Combining therapies with different mechanisms of action to treat non-alcoholic fatty liver disease resulted in greater reduction in liver-related measures, according to a presenter at The Liver Meeting Digital Experience.

News
November 15, 2020
1 min read
Save

Genetic, metabolic score stratifies risk for adverse events in fatty liver

Using genetic markers with metabolic risk factors can predict an individual patient’s risk for developing liver related events due to non-alcoholic fatty liver disease, according to a researcher at The Liver Meeting Digital Experience.

News
November 09, 2020
2 min read
Save

NAFLD screening falls short of guidelines for children with obesity

NAFLD screening falls short of guidelines for children with obesity

Most children with obesity who are at high risk for non-alcoholic fatty liver disease are not being screened, possibly leading to underdiagnosis of the condition, according to a speaker at ObesityWeek Interactive.

News
October 29, 2020
1 min read
Save

Cannabis reduces prevalence, progression of steatohepatitis in obese patients

Cannabis reduces prevalence, progression of steatohepatitis in obese patients

Cannabis use correlated with a decreased prevalence and progression of steatohepatitis among patients who were obese, according to results presented at the American College of Gastroenterology Virtual Annual Meeting.

News
October 22, 2020
1 min read
Save

Weight loss after sleeve gastrectomy significantly improves liver histopathology

Weight loss after a laparoscopic sleeve gastrectomy correlated with significant improvements in metabolic parameters, liver enzyme levels and liver histopathology, according to study results.

News
October 08, 2020
2 min read
Save

CMHC announces six-part live multidisciplinary CME/CE series

CMHC announces six-part live multidisciplinary CME/CE series

The Cardiometabolic Health Congress announced the launch of a live and archived CME/CE six-part specialty series.

View more